Format

Send to

Choose Destination
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S147-54. doi: 10.1093/cid/civ579.

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Author information

1
Tuberculosis Modelling Group, Centre for the Mathematical Modelling of Infectious Diseases, Tuberculosis Centre, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine.
2
Department of Mathematics, Imperial College London, United Kingdom.
3
Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
4
Amsterdam Institute for Global Health and Development, Academic Medical Center KNCV Tuberculosis Foundation, The Hague, The Netherlands.
5
Department of Epidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, Connecticut.

Abstract

BACKGROUND:

Drug resistance poses a serious challenge for the control of tuberculosis in many settings. It is well established that the expected future trend in resistance depends on the reproductive fitness of drug-resistant Mycobacterium tuberculosis. However, the variability in fitness between strains with different resistance-conferring mutations has been largely ignored when making these predictions.

METHODS:

We developed a novel approach for incorporating the variable fitness costs of drug resistance-conferring mutations and for tracking this distribution of fitness costs over time within a transmission model. We used this approach to describe the effects of realistic fitness cost distributions on the future prevalence of drug-resistant tuberculosis.

RESULTS:

The shape of the distribution of fitness costs was a strong predictor of the long-term prevalence of resistance. While, as expected, lower average fitness costs of drug resistance-conferring mutations were associated with more severe epidemics of drug-resistant tuberculosis, fitness distributions with greater variance also led to higher levels of drug resistance. For example, compared to simulations in which the fitness cost of resistance was fixed, introducing a realistic amount of variance resulted in a 40% increase in prevalence of drug-resistant tuberculosis after 20 years.

CONCLUSIONS:

The differences in the fitness costs associated with drug resistance-conferring mutations are a key determinant of the future burden of drug-resistant tuberculosis. Future studies that can better establish the range of fitness costs associated with drug resistance-conferring mutations will improve projections and thus facilitate better public health planning efforts.

KEYWORDS:

antibiotic resistance; fitness costs; mathematical modeling; tuberculosis

PMID:
26409276
PMCID:
PMC4583567
DOI:
10.1093/cid/civ579
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center